Our findings provide a possible therapeutic strategy whereby inactivation of Id1 may lead to sensitisation of LMP1-positive NPC cells to chemotherapeutic drug induced apoptosis. The gene discussed is ID1; the disease is nasopharyngeal carcinoma.